Eptinezumab (Anti-CALCA / CGRP)

Eptinezumab (Anti-CALCA / CGRP) is a humanized monoclonal antibody that binds to calcitoninĀ gene-related peptide (CGRP) and blocks its binding to the receptor. It is used in the preventive treatment of episodic migraine. MW: 143.36 kD.
Supplier Selleck Chemicals
Product # A2790
Sku # A2790-1mg
Pricing 1mg, $370.00
Feedback